ArticleImmunology and cell biology2021

Interleukin-1β exacerbates disease and is a potential therapeutic target to reduce pulmonary inflammation during severe influenza A virus infection.

Abdulah Os Bawazeer et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.